Iridex (IRIX) Notes Payables (2011 - 2024)

Iridex (IRIX) posted quarterly Notes Payables of $1.7 million for Q4 2024, up 31.96% quarter-over-quarter from $1.3 million in Q3 2024.

Iridex (IRIX) Notes Payables (2011 - 2024) Analysis & Trends

Iridex's Notes Payables history runs 9 years deep, the most recent figure standing at $1.7 million for Q4 2024.

In Q4 2024, Notes Payables changed N/A year-over-year to $1.7 million; the TTM figure through Dec 2024 stood at $1.7 million (changed N/A YoY), while the FY2024 annual figure was $1.7 million, changed N/A from the prior year.
Notes Payables for Q4 2024 stood at $1.7 million, up from $1.3 million in the prior quarter.
The five-year high for Notes Payables was $1.7 million in Q4 2024, with the low at $15000.0 in Q4 2022.
The 3-year median for Notes Payables is $403500.0 (2022), against an average of $624125.0.
The sharpest annual moves came in 2022 and 2023: Notes Payables tumbled 97.61% in 2022, then sank 86.32% in 2023.
Iridex's Notes Payables stood at $15000.0 in 2022, then jumped by 720.0% to $123000.0 in 2023, then surged by 1309.76% to $1.7 million in 2024.
Business Quant data shows IRIX's Notes Payables at $1.7 million in Q4 2024, $1.3 million in Q3 2024, and $123000.0 in Q2 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Iridex	13.27 Mn	8.59 Mn	4.30 Mn

Download Data